The Philadelphia Eagles will not face repercussions for their management of quarterback Jalen Hurts’ recent health issues, according to a statement from the NFL. This decision follows Hurts’ diagnosis of blood clots, specifically deep vein thrombosis and pulmonary emboli, which he sustained during the season.
On Tuesday, the league clarified that they had maintained ongoing communication with the Eagles’ medical team and specialists from the Cleveland Clinic in London, where Hurts received treatment. The NFL’s Chief Medical Officer, Dr. Allen Sills, emphasized the importance of coordination between club medical staff and independent doctors in ensuring player safety.
Hurts, who is currently on injured reserve, is expected to miss the remainder of the season due to the complications arising from the blood clots, which notably traveled from his calf to his lungs. His treatment regimen includes blood thinners, necessitating his exclusion from any football-related activities until he is cleared.
Notably, Hurts played against the Jacksonville Jaguars on October 11, just a day after receiving his initial diagnosis of a left calf superficial vein thrombosis. The incident has raised questions regarding the decision to allow him to participate in that game.
The NFL plans to address the media later today during their annual fall meeting in New York, where further discussions on player health and safety are anticipated.
Photo credit: Ryan Pierse
